Search Results - "Hariharan, Vignesh"
-
1
Chemical optimization of siRNA for safe and efficient silencing of placental sFLT1
Published in Molecular therapy. Nucleic acids (13-09-2022)“…Preeclampsia (PE) is a rising, potentially lethal complication of pregnancy. PE is driven primarily by the overexpression of placental soluble fms-like…”
Get full text
Journal Article -
2
Phosphatidylcholine head group chemistry alters the extrahepatic accumulation of lipid-conjugated siRNA
Published in Molecular therapy. Nucleic acids (11-06-2024)“…Small interfering RNAs (siRNAs) are revolutionizing the treatment of liver-associated indications. Yet, robust delivery to extrahepatic tissues remains a…”
Get full text
Journal Article -
3
Divalent siRNAs are bioavailable in the lung and efficiently block SARS-CoV-2 infection
Published in Proceedings of the National Academy of Sciences - PNAS (14-03-2023)“…The continuous evolution of SARS-CoV-2 variants complicates efforts to combat the ongoing pandemic, underscoring the need for a dynamic platform for the rapid…”
Get full text
Journal Article -
4
Rational design of a JAK1-selective siRNA inhibitor for the modulation of autoimmunity in the skin
Published in Nature communications (04-11-2023)“…Inhibition of Janus kinase (JAK) family enzymes is a popular strategy for treating inflammatory and autoimmune skin diseases. In the clinic, small molecule JAK…”
Get full text
Journal Article -
5
Enhancing siRNA efficacy in vivo with extended nucleic acid backbones
Published in Nature biotechnology (01-08-2024)“…Therapeutic small interfering RNA (siRNA) requires sugar and backbone modifications to inhibit nuclease degradation. However, metabolic stabilization by…”
Get full text
Journal Article -
6
Dendritic amphiphilic siRNA: Selective albumin binding, in vivo efficacy, and low toxicity
Published in Molecular therapy. Nucleic acids (12-12-2023)“…Although an increasing number of small interfering RNA (siRNA) therapies are reaching the market, the challenge of efficient extra-hepatic delivery continues…”
Get full text
Journal Article -
7
Antiplatelet Treatment Patterns and Outcomes for Secondary Stroke Prevention in the United Kingdom
Published in Cardiology and therapy (01-12-2023)“…Introduction Stroke is a leading cause of death and disability worldwide. Antiplatelet therapies are recommended to reduce the risk of recurrent stroke in…”
Get full text
Journal Article -
8
Docosanoic acid conjugation to siRNA enables functional and safe delivery to skeletal and cardiac muscles
Published in Molecular therapy (07-04-2021)“…Oligonucleotide therapeutics hold promise for the treatment of muscle- and heart-related diseases. However, oligonucleotide delivery across the continuous…”
Get full text
Journal Article -
9
Cyclic di‐GMP sensing histidine kinase PdtaS controls mycobacterial adaptation to carbon sources
Published in The FASEB journal (01-04-2021)“…Cell signaling relies on second messengers to transduce signals from the sensory apparatus to downstream signaling pathway components. In bacteria, one of the…”
Get full text
Journal Article -
10
Di-valent siRNA-mediated silencing of MSH3 blocks somatic repeat expansion in mouse models of Huntington’s disease
Published in Molecular therapy (07-06-2023)“…Huntington’s disease (HD) is a severe neurodegenerative disorder caused by the expansion of the CAG trinucleotide repeat tract in the huntingtin gene…”
Get full text
Journal Article -
11
Abstract WP7: Utilization and Outcomes Associated With DAPT and ASA Monotherapy Amongst Hospitalizations With Large Vessel Occlusion: A Nationwide Cross-Sectional Analysis
Published in Stroke (1970) (01-02-2024)“…Abstract only Background: In clinical trials like SPS3, MATCH, CHANCE, and POINT, dual antiplatelet treatment (DAPT) has been compared to aspirin (ASA) alone…”
Get full text
Journal Article -
12
Challenges of Assessing Exon 53 Skipping of the Human DMD Transcript with Locked Nucleic Acid-Modified Antisense Oligonucleotides in a Mouse Model for Duchenne Muscular Dystrophy
Published in Nucleic acid therapeutics (01-12-2023)“…Antisense oligonucleotide (AON)-mediated exon skipping is a promising therapeutic approach for Duchenne muscular dystrophy (DMD) patients to restore dystrophin…”
Get more information
Journal Article -
13
Phosphocholine Headgroup Chemistry Alters the Extrahepatic Accumulation of Lipid Conjugated siRNA
Published in Molecular therapy. Nucleic acids (01-05-2024)Get full text
Journal Article -
14
A combinatorial approach for achieving CNS-selective RNAi
Published in Nucleic acids research (22-05-2024)“…RNA interference (RNAi) is an endogenous process that can be harnessed using chemically modified small interfering RNAs (siRNAs) to potently modulate gene…”
Get full text
Journal Article -
15
Di-valent siRNA-mediated silencing of MSH3 blocks somatic repeat expansion in mouse models of Huntington’s disease
Published in Molecular therapy (01-11-2023)Get full text
Journal Article -
16
A serpentine way to signaling: Nobel Prize in Chemistry, 2012
Published in Resonance (01-06-2013)“…The Nobel Prize in Chemistry, 2012 has been awarded to Robert J Lefkowitz and Brian K Kobilka for their studies on G-Protein Coupled Receptors (GPCRs). GPCRs…”
Get full text
Journal Article -
17
A Review on NFC for Secure Transaction its Fundamental Challenges and Future Directions
Published in 2024 International Conference on Advances in Computing Research on Science Engineering and Technology (ACROSET) (27-09-2024)“…Near-Field Communication (NFC) payment solutions are contactless payment solutions which harness the short-range communication capabilities and existing RFID…”
Get full text
Conference Proceeding